Korea adjusted the existing evaluation requirements for quasi drugs to align with the new quasi drug reevaluation scheme implemented on December 4th 2015.
Korea adjusted the existing evaluation requirements for quasi drugs to align with the new quasi drug reevaluation scheme implemented on December 4th 2015. Enlarge the scope of high risk ingredients MFDS newly adds polyhexamethylene guanidine hydrochloride (PHMG), oligo (2-2-ethyoxy) ethoxyethylguanidim chloride (PGH), cetylpyridinum chloride (CPC) -- when concentration above 0.05%, and dipropylisocinchomeronate into the scope of high risk ingredients which can potentially cause cellular damage. Both PHMG and PGH have been discovered as risk factors in the development of lung disease if inhaled. The preparations of inhalation, spray,
Korea adjusted the existing evaluation requirements for quasi drugs to align with the new quasi drug reevaluation scheme implemented on December 4th 2015.